CEO Series: 23andMe’s Anne Wojcicki on Scientific Breakthroughs and Public Trust

Anne Wojcicki, CEO of 23andMe, is a visionary in DNA testing and personalized medicine. She discusses the challenges of leading a groundbreaking company at the intersection of science and consumer trust. Wojcicki highlights the importance of transparency in data privacy, enabling informed choices. She also shares insights on the role of genetic research during the COVID-19 pandemic, revealing intriguing findings about blood type O. Lastly, she reflects on the competitive landscape of genetic testing and the potential of direct-to-consumer healthcare in improving personal health decisions.